Beta-3 Adrenoreceptor: Boon or Bane in Heart Failure?

G. Paas, Jeremy Owen G. Go, Ezekiel Morena S. Rivera, Margarita Ysabel S. Mangahas, Eunice Marie Perez-Trajano, Raul D. Jara
{"title":"Beta-3 Adrenoreceptor: Boon or Bane in Heart Failure?","authors":"G. Paas, Jeremy Owen G. Go, Ezekiel Morena S. Rivera, Margarita Ysabel S. Mangahas, Eunice Marie Perez-Trajano, Raul D. Jara","doi":"10.33425/2639-8486.1079","DOIUrl":null,"url":null,"abstract":"Inclusion criteria We included published studies on humans, review articles, and experimental studies in human tissues published in PubMed, MEDLINE, Herdin, and Cochrane which discussed the effects ABSTRACT Background: In a recent publication, four beta blockers—Metoprolol, Carvedilol, Bisoprolol, and Nebivolol have shown good effects in heart failure. Published studies on the role of beta-3 receptor (B3AR) agonism over the past 3 decades had conflicting results. Recent experimental studies described its role in coupling mechanisms with nitric oxide, offering protection in damaged cardiac myocytes.","PeriodicalId":72522,"journal":{"name":"Cardiology & vascular research (Wilmington, Del.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology & vascular research (Wilmington, Del.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33425/2639-8486.1079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Inclusion criteria We included published studies on humans, review articles, and experimental studies in human tissues published in PubMed, MEDLINE, Herdin, and Cochrane which discussed the effects ABSTRACT Background: In a recent publication, four beta blockers—Metoprolol, Carvedilol, Bisoprolol, and Nebivolol have shown good effects in heart failure. Published studies on the role of beta-3 receptor (B3AR) agonism over the past 3 decades had conflicting results. Recent experimental studies described its role in coupling mechanisms with nitric oxide, offering protection in damaged cardiac myocytes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
-3肾上腺素受体:对心力衰竭有利还是有害?
摘要背景:在最近发表的一篇文章中,四种受体阻滞剂——美托洛尔、卡维地洛、比索洛尔和内比洛尔在心力衰竭中显示出良好的疗效。在过去的30年里,关于β -3受体(B3AR)激动作用的已发表的研究结果相互矛盾。最近的实验研究描述了它在与一氧化氮偶联机制中的作用,为受损的心肌细胞提供保护。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Stroke Subtypes, Risk Factors and Treatment Outcomes at A Tertiary Hospital Situated in Rural Southwestern Nigeria: A Five- Year Restrospective Observational Study Prevalence of Metabolic Syndrome Components among EarlyAge onset Acute Coronary Syndrome Patients in Bangladesh Aortic Dissection Involving a Right Retroesophagian Subclaviary Artery (LUSORIA) Associated with a Bi-Carotidian Trunk: About a Case at the National University Hospital Center of Fann (Sénégal) Use of Left Ventricular Global Longitudinal Strain to predict Reverse Left Ventricular Remodeling after MitraClip Repair Can Early Diagnosis - Treatment of A Hemodynamically Significant Patent Ductus Arteriosus Reduce the Incidence of Pulmonary Hemorrhage in Extreme Low Birth Weight Infants?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1